Skip to main content
Premium Trial:

Request an Annual Quote

PE Biosystems to Acquire Third Wave for $325 Million

Premium

F

OSTER CITY, Calif.--PE Biosystems Group is set to acquire Third Wave Technologies for $325.1 million in stock, according to a Bloomberg News report. PE Biosystems will give up 1.97 million common shares for the six-year old company with 120 employees in Madison, Wis. The PE subsidiary will get Third Wave’s Invader nucleic acid detection technology, which it hopes will accelerate its pharmacogenomics efforts in identifying which genes are involved in specific diseases, and how patients might respond to certain treatments.

Third Wave recently announced that it is collaborating with the Sanger Centre to use Invader to construct the first high-density SNP map of a human chromosome (chromsome 22) and corresponding SNP test panel.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.